Pharmacist GI Podcast 30m

Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition.

Learning Objectives

Upon successful completion of this course, learners should be able to:
1. Describe current terminology, risk factors, and stages associated with fatty liver disease.
2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.

Faculty

Joshua Davis Kinsey, PharmD

VP, Education
CEimpact

Disclosures:

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Sarah Wheeler, PharmD, BCACP, CDCES

Assistant Professor
VCU School of Pharmacy

Disclosures:

Sarah Wheeler is a Contract Medical Writer for Banner Medical, LLC. All relevant financial relationships have been mitigated.

Course Details